Nobuo Nagano

2.7k total citations
87 papers, 2.1k citations indexed

About

Nobuo Nagano is a scholar working on Nephrology, Nutrition and Dietetics and Molecular Biology. According to data from OpenAlex, Nobuo Nagano has authored 87 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Nephrology, 21 papers in Nutrition and Dietetics and 18 papers in Molecular Biology. Recurrent topics in Nobuo Nagano's work include Parathyroid Disorders and Treatments (41 papers), Magnesium in Health and Disease (19 papers) and Genetic Syndromes and Imprinting (14 papers). Nobuo Nagano is often cited by papers focused on Parathyroid Disorders and Treatments (41 papers), Magnesium in Health and Disease (19 papers) and Genetic Syndromes and Imprinting (14 papers). Nobuo Nagano collaborates with scholars based in Japan, United States and Singapore. Nobuo Nagano's co-authors include Michihito Wada, Edward F. Nemeth, Hiromi Ishii, M. Wada, John Fox, Yoshihiro FURUYA, Nobuhiko Kobayashi, Y Furuya, Toshiro Fujita and Naoshi Fukushima and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Scientific Reports.

In The Last Decade

Nobuo Nagano

82 papers receiving 2.0k citations

Peers

Nobuo Nagano

NEPHR

GENET

PFM

Theresa J. Berndt United States

Eva Parisi Spain

H. T. Keutmann United States

Takayasu Mori Japan

Per Svenningsen Denmark

Michael I. Oliverio United States

Hee‐Seong Jang South Korea

Susana López‐Ongil Spain

Karen L. Hile United States

Jee In Kim South Korea

Theresa J. Berndt United States

Nobuo Nagano

1.1k ×0.7

NEPHR

425 ×0.7

480 ×0.9

GENET

524 ×1.1

247 ×0.5

PFM

Citations per year, relative to Nobuo Nagano Nobuo Nagano (= 1×) peers Theresa J. Berndt

Countries citing papers authored by Nobuo Nagano

Since Specialization

Citations

This map shows the geographic impact of Nobuo Nagano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Nagano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Nagano more than expected).

Fields of papers citing papers by Nobuo Nagano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Nagano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Nagano. The network helps show where Nobuo Nagano may publish in the future.

Co-authorship network of co-authors of Nobuo Nagano

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Nagano. A scholar is included among the top collaborators of Nobuo Nagano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Nagano. Nobuo Nagano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagano, Nobuo, Takayuki Ishikawa, Masashi Yamaguchi, et al.. (2024). Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients. Renal Replacement Therapy. 10(1). 1 indexed citations

Nagano, Nobuo, et al.. (2016). [Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator].. PubMed. 26(6). 839–50. 2 indexed citations

Nagano, Nobuo, Tetsuo Ando, Kyoko Ito, & Yoshitaka Ando. (2012). [Cinacalcet hydrochloride and phosphate metabolism].. PubMed. 22(10). 1567–76. 2 indexed citations

Imanishi, Yasuo, Takehisa Kawata, Michihito Wada, et al.. (2011). Cinacalcet HCl Suppresses Cyclin D1 Oncogene-Derived Parathyroid Cell Proliferation in a Murine Model for Primary Hyperparathyroidism. Calcified Tissue International. 89(1). 29–35. 14 indexed citations

Hasegawa, Hisashi, Nobuo Nagano, Itaru Urakawa, et al.. (2010). Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney International. 78(10). 975–980. 251 indexed citations

Kawata, Takehisa, et al.. (2008). Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney International. 74(10). 1270–1277. 85 indexed citations

Nagano, Nobuo, et al.. (2006). Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney International. 69(3). 531–537. 116 indexed citations

Kawata, Takehisa & Nobuo Nagano. (2005). [The calcium receptor and magnesium metabolism].. PubMed. 15(11). 43–50. 1 indexed citations

Kawata, Takehisa, Yasuo Imanishi, Keisuke Kobayashi, et al.. (2005). Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism. European Journal of Endocrinology. 153(4). 587–594. 26 indexed citations

10.

Nagano, Nobuo. (2005). [Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics)--effect on the set point of calcium-regulated PTH secretion].. PubMed. 15(1). 71–8. 1 indexed citations

11.

Nagano, Nobuo. (2003). Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency. Nephrology Dialysis Transplantation. 18(10). 2014–2023. 43 indexed citations

12.

Katsumata, Kyoko S., Kenichiro Kusano, Michinori Hirata, et al.. (2003). Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney International. 64(2). 441–450. 138 indexed citations

13.

Nagano, Nobuo & Naoshi Fukushima. (2003). Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients.. Folia Pharmacologica Japonica. 122(5). 443–453. 5 indexed citations

14.

Nangaku, Masaomi, Daisuke Suzuki, Tomoya Umezono, et al.. (2001). Cloning of rodent megsin revealed its up-regulation in mesangioproliferative nephritis. Kidney International. 60(2). 641–652. 22 indexed citations

15.

Wada, Michihito, et al.. (2000). Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism. Kidney International. 57(1). 50–58. 105 indexed citations

16.

Yagi, Mikio, Tadashi Yamamoto, Shinichiro Kato, Nobuo Nagano, & Itaru Kihara. (1998). Long‐term observation of glomerulonephritis induced by multiple injections with anti‐Thy‐1 antibody in rats. Pathology International. 48(7). 491–498. 6 indexed citations

17.

Yoshimoto, Hiroshi, Tsuyoshi Nishitoba, Nobuo Nagano, et al.. (1996). An Investigation on Stability of Chitosan-Coated Dialdehyde Cellulose at Physiological pH Condition. 2(1). 9–15.

18.

MANABE, Noboru, et al.. (1995). Immunohistochemical microquantification of fast-myosin in frozen histological sections of mammalian skeletal muscles.. Journal of Animal Science. 73(1). 88–88. 7 indexed citations

19.

MANABE, Noboru, et al.. (1994). A New Immunohistochemical Method for Quantification of Fast-Myosin in Frozen Histologic Sections of the Rat Skeletal Muscles.. Journal of Veterinary Medical Science. 56(1). 7–13. 3 indexed citations

20.

Nagano, Nobuo, et al.. (1988). The spinal reflex of chronic spinal rats is supersensitive to 5-HTP but not to TRH or 5-HT agonists. European Journal of Pharmacology. 149(3). 337–344. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact